查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1417541

C反應蛋白(CRP)測試市場報告：至2030年的趨勢、預測和競爭分析

C-Reactive Protein Testing Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

C反應蛋白檢測的趨勢與預測

到2030年，全球C反應蛋白檢測市場預計將達到 61 億美元，2024年至2030年年複合成長率為 2.8%。該市場的主要驅動力是心血管疾病發病率的上升，目的是引進照護現場篩檢和開發C反應蛋白（CRP）檢測尖端方法的政府計劃的擴大，以及慢性病發病率的增加例如心血管疾病、類風濕性關節炎和發炎疾病。全球C反應蛋白檢測市場的未來前景廣闊，診所、醫院、實驗室、輔助生活醫療機構、家庭市場等領域都有機會。

C-反應蛋白測試市場洞察

Lucintel 預測，由於心血管疾病的發生率不斷增加，心血管疾病在預測期內仍將是最大的細分市場。

由於心血管疾病盛行率上升、產品推出頻繁以及現有行業競爭對手的存在，北美在預測期內將繼續成為最大的地區。

常問問題

Q1.市場規模有多大？

A1.到2030年，全球C反應蛋白檢測市場預計將達到 61 億美元。

Q2.市場成長預測如何？

A2.2024年至2030年，全球C反應蛋白檢測市場預計將以2.8%的年複合成長率成長。

Q3.影響市場成長的主要促進因素有哪些？

A3.該市場的主要驅動力是心血管疾病發病率的上升、目的是引進照護現場和開發C反應蛋白（CRP）檢測尖端方法的政府計劃的擴大；以及慢性病患病率的增加例如心血管疾病、類風濕性關節炎和發炎疾病。

Q4.市場的主要細分市場是什麼？

A4.全球C 反應蛋白檢測市場的未來對於診所、醫院、實驗室、輔助生活醫療機構和家庭市場來說都是充滿希望的。

Q5.市場上主要企業有哪些？

A5.主要C反應蛋白檢測公司如下。

  • Thermo Fisher Scientific
  • F. Hoffmann-La Roche
  • Danaher
  • Quest Diagnostics
  • Siemens Healthineers
  • Abbott
  • Merck
  • Zoetis
  • Ortho Clinical Diagnostics
  • Getein Biotech

Q6.未來最大的細分市場是什麼？

A6.Lucintel 預計，由於心血管疾病的發生率不斷增加，心血管疾病在預測期內仍將是其最大的細分市場。

Q7.未來五年預計哪個地區將成為最大的市場？

A7.由於心血管疾病盛行率上升、產品推出頻繁以及現有產業競爭對手的存在，北美在預測期內將繼續成為最大的地區。

Q8.可以客製化報告嗎？

A8.是的，Lucintel 提供 10%的客製化服務，無需額外付費。

目錄

第1章 執行摘要

第2章 全球C反應蛋白檢測市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球C反應蛋白檢測市場趨勢（2018-2023）與預測（2024-2030）
  • 按檢測法分類的全球C反應蛋白檢測市場
    • 檢測法
    • 酵素連結免疫吸附法
    • 化學冷光免疫檢測
    • 其他
  • 按檢測範圍分類的全球C反應蛋白檢測市場
    • hsCRP（高敏感性CRP）
    • 常規CRP
    • cCRP（CardioPhase）
  • 依疾病分類的全球C反應蛋白檢測市場
    • 心血管疾病
    • 癌症
    • 類風濕性關節炎
    • 發炎性腸道疾病
    • 子宮內膜異位症
    • 狼瘡
    • 其他
  • 依最終用途分類的全球C反應蛋白測試市場
    • 診所
    • 醫院
    • 實驗室
    • 生活支援醫療設施
    • 在家裡
    • 其他

第4章 2018-2030年區域市場趨勢及預測分析

  • 依地區分類的全球C反應蛋白檢測市場
  • 北美C反應蛋白檢測市場
  • 歐洲C反應蛋白檢測市場
  • 亞太C反應蛋白檢測市場
  • 其他地區C反應蛋白檢測市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 按檢測類型分類的全球C反應蛋白檢測市場成長機會
    • 按檢測範圍分類的全球C反應蛋白檢測市場成長機會
    • 依疾病分類的全球C反應蛋白檢測市場成長機會
    • 依最終用途分類的全球C反應蛋白測試市場的成長機會
    • 依地區分類的全球C反應蛋白測試市場成長機會
  • 全球C反應蛋白檢測市場的新趨勢
  • 戰略分析
    • 新產品開發
    • 全球C反應蛋白檢測市場的產能擴張
    • 全球C反應蛋白檢測市場的合併、收購與合資
    • 認證和許可

第7章 主要企業概況

  • Thermo Fisher Scientific
  • F. Hoffmann-La Roche
  • Danaher
  • Quest Diagnostics
  • Siemens Healthineers
  • Abbott
  • Merck
  • Zoetis
  • Ortho Clinical Diagnostics
  • Getein Biotech
簡介目錄

C-Reactive Protein Testing Trends and Forecast

The future of the global C-reactive protein testing market looks promising with opportunities in the clinic, hospital, laboratories, assisted living healthcare facilities, and home markets. The global C-reactive protein testing market is expected to reach an estimated $6.1 billion by 2030 with a CAGR of 2.8% from 2024 to 2030. The major drivers for this market are rising frequency of cardiovascular disorders, expanding government programs to introduce point-of-care screening and create cutting-edge methods for C-reactive protein (CRP) testing, as well as, increasing rates of chronic illnesses such cardiovascular disease, rheumatoid arthritis, and inflammatory disorders.

A more than 150-page report is developed to help in your business decisions.

C-Reactive Protein Testing by Segment

The study includes a forecast for the global C-reactive protein testing by assay type, detection range, disease, end use, and region.

C-Reactive Protein Testing Market by Assay Type [Shipment Analysis by Value from 2018 to 2030]:

  • Immunoturbidimetric Assay
  • ELISA
  • Chemiluminescence Immunoassay
  • Others

C-Reactive Protein Testing Market by Detection Range [Shipment Analysis by Value from 2018 to 2030]:

  • hs-CRP
  • Conventional CRP
  • cCRP

C-Reactive Protein Testing Market by Disease [Shipment Analysis by Value from 2018 to 2030]:

  • Cardiovascular Diseases
  • Cancer
  • Rheumatoid Arthritis
  • Inflammatory Bowel Disease
  • Endometriosis
  • Lupus
  • Others

C-Reactive Protein Testing Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Clinics
  • Hospitals
  • Laboratories
  • Assisted Living Healthcare Facilities
  • Home
  • Others

C-Reactive Protein Testing Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of C-Reactive Protein Testing Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies C-reactive protein testing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the C-reactive protein testing companies profiled in this report include-

  • Thermo Fisher Scientific
  • F. Hoffmann-La Roche
  • Danaher
  • Quest Diagnostics
  • Siemens Healthineers
  • Abbott
  • Merck
  • Zoetis
  • Ortho Clinical Diagnostics
  • Getein Biotech

C-Reactive Protein Testing Market Insights

Lucintel forecasts that cardiovascular diseases will remain the largest segment over the forecast period due to the rise in the frequency of cardiovascular disorders.

North America will remain the largest region over the forecast period due to rising cardiovascular disease incidence, a regular stream of product introductions, and the existence of established industry competitors.

Features of the Global C-Reactive Protein Testing Market

Market Size Estimates: C-reactive protein testing market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: C-reactive protein testing market size by various segments, such as by assay type, detection range, disease, end use, and region in terms of value ($B).

Regional Analysis: C-reactive protein testing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different assay type, detection range, disease, end use, and regions for the C-reactive protein testing market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the C-reactive protein testing market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the C-reactive protein testing market size?

Answer: The global C-reactive protein testing market is expected to reach an estimated $6.1 billion by 2030.

Q2. What is the growth forecast for C-reactive protein testing market?

Answer: The global C-reactive protein testing market is expected to grow with a CAGR of 2.8% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the C-reactive protein testing market?

Answer: The major drivers for this market are rising frequency of cardiovascular disorders, expanding government programs to introduce point-of-care screening and create cutting-edge methods for C-reactive protein (CRP) testing, as well as, increasing rates of chronic illnesses such cardiovascular disease, rheumatoid arthritis, and inflammatory disorders.

Q4. What are the major segments for C-reactive protein testing market?

Answer: The future of the global C-reactive protein testing market looks promising with opportunities in the clinic, hospital, laboratories, assisted living healthcare facilities, and home markets.

Q5. Who are the key C-reactive protein testing market companies?

Answer: Some of the key C-reactive protein testing companies are as follows.

  • Thermo Fisher Scientific
  • F. Hoffmann-La Roche
  • Danaher
  • Quest Diagnostics
  • Siemens Healthineers
  • Abbott
  • Merck
  • Zoetis
  • Ortho Clinical Diagnostics
  • Getein Biotech

Q6. Which C-reactive protein testing market segment will be the largest in future?

Answer: Lucintel forecasts that cardiovascular diseases will remain the largest segment over the forecast period due to the rise in the frequency of cardiovascular disorders.

Q7. In C-reactive protein testing market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to rising cardiovascular disease incidence, a regular stream of product introductions, and the existence of established industry competitors.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the C-reactive protein testing market by assay type (immunoturbidimetric assay, elisa, chemiluminescence immunoassay, and others), detection range (hs-CRP, conventional CRP, and cCRP), disease (cardiovascular diseases, cancer, rheumatoid arthritis, inflammatory bowel disease, endometriosis, lupus, and others), end use (clinics, hospitals, laboratories, assisted living healthcare facilities, home, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global C-Reactive Protein Testing Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global C-Reactive Protein Testing Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global C-Reactive Protein Testing Market by Assay Type
    • 3.3.1: Immunoturbidimetric Assay
    • 3.3.2: ELISA
    • 3.3.3: Chemiluminescence Immunoassay
    • 3.3.4: Others
  • 3.4: Global C-Reactive Protein Testing Market by Detection Range
    • 3.4.1: hs-CRP
    • 3.4.2: Conventional CRP
    • 3.4.3: cCRP
  • 3.5: Global C-Reactive Protein Testing Market by Disease
    • 3.5.1: Cardiovascular Diseases
    • 3.5.2: Cancer
    • 3.5.3: Rheumatoid Arthritis
    • 3.5.4: Inflammatory Bowel Disease
    • 3.5.5: Endometriosis
    • 3.5.6: Lupus
    • 3.5.7: Others
  • 3.6: Global C-Reactive Protein Testing Market by End Use
    • 3.6.1: Clinics
    • 3.6.2: Hospitals
    • 3.6.3: Laboratories
    • 3.6.4: Assisted Living Healthcare Facilities
    • 3.6.5: Home
    • 3.6.6: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global C-Reactive Protein Testing Market by Region
  • 4.2: North American C-Reactive Protein Testing Market
    • 4.2.1: North American C-Reactive Protein Testing Market by Disease: Cardiovascular Diseases, Cancer, Rheumatoid Arthritis, Inflammatory Bowel Disease, Endometriosis, Lupus, and Others
    • 4.2.2: North American C-Reactive Protein Testing Market by End Use: Clinics, Hospitals, Laboratories, Assisted Living Healthcare Facilities, Home, and Others
  • 4.3: European C-Reactive Protein Testing Market
    • 4.3.1: European C-Reactive Protein Testing Market by Disease: Cardiovascular Diseases, Cancer, Rheumatoid Arthritis, Inflammatory Bowel Disease, Endometriosis, Lupus, and Others
    • 4.3.2: European C-Reactive Protein Testing Market by End Use: Clinics, Hospitals, Laboratories, Assisted Living Healthcare Facilities, Home, and Others
  • 4.4: APAC C-Reactive Protein Testing Market
    • 4.4.1: APAC C-Reactive Protein Testing Market by Disease: Cardiovascular Diseases, Cancer, Rheumatoid Arthritis, Inflammatory Bowel Disease, Endometriosis, Lupus, and Others
    • 4.4.2: APAC C-Reactive Protein Testing Market by End Use: Clinics, Hospitals, Laboratories, Assisted Living Healthcare Facilities, Home, and Others
  • 4.5: ROW C-Reactive Protein Testing Market
    • 4.5.1: ROW C-Reactive Protein Testing Market by Disease: Cardiovascular Diseases, Cancer, Rheumatoid Arthritis, Inflammatory Bowel Disease, Endometriosis, Lupus, and Others
    • 4.5.2: ROW C-Reactive Protein Testing Market by End Use: Clinics, Hospitals, Laboratories, Assisted Living Healthcare Facilities, Home, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global C-Reactive Protein Testing Market by Assay Type
    • 6.1.2: Growth Opportunities for the Global C-Reactive Protein Testing Market by Detection Range
    • 6.1.3: Growth Opportunities for the Global C-Reactive Protein Testing Market by Disease
    • 6.1.4: Growth Opportunities for the Global C-Reactive Protein Testing Market by End Use
    • 6.1.5: Growth Opportunities for the Global C-Reactive Protein Testing Market by Region
  • 6.2: Emerging Trends in the Global C-Reactive Protein Testing Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global C-Reactive Protein Testing Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global C-Reactive Protein Testing Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Thermo Fisher Scientific
  • 7.2: F. Hoffmann-La Roche
  • 7.3: Danaher
  • 7.4: Quest Diagnostics
  • 7.5: Siemens Healthineers
  • 7.6: Abbott
  • 7.7: Merck
  • 7.8: Zoetis
  • 7.9: Ortho Clinical Diagnostics
  • 7.10: Getein Biotech